Product information
Tesamorelin
GHRH Analog for Laboratory Research
$69.99
Overview
Tesamorelin is a synthetic 44-amino-acid analog of human growth hormone-releasing hormone, also called growth hormone-releasing factor. Its backbone matches human GHRH(1-44) and includes an N-terminal trans-3-hexenoyl modification that increases resistance to enzymatic breakdown.
This tesamorelin research material is not an FDA-approved drug and is not represented as equivalent or substitutable for any prescription tesamorelin formulation. For laboratory research use only. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Research Details
In laboratory models, tesamorelin binds to and activates the human GHRH receptor. This G-protein-coupled receptor is involved in cyclic AMP signaling and regulation of the growth hormone and IGF-1 axis. Tesamorelin has been studied in receptor-binding assays, endocrine-feedback models, peptide-stability analysis, and pulsatile hormone signaling.
Controlled research has examined its effect on growth-hormone pulsatility and related endocrine markers. Its molecular structure and receptor activity are also described in FDA-approved product labeling.
Research areas include:
- GHRH-receptor binding and activation assays
- Cyclic AMP signaling research
- Growth hormone and IGF-1 axis research
- Endocrine-feedback and pulsatility studies
- Peptide-stability and degradation analysis
- Comparative GHRH-analog characterization
Shipping
Shipping options and details are confirmed at checkout or by support.
Research-Use Disclaimer
This tesamorelin research material is not an FDA-approved drug and is not represented as equivalent or substitutable for any prescription tesamorelin formulation. For laboratory research use only. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Support
Need help with an order?
For questions about shipping, orders, returns, or your account, contact our support team.
